• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Transporting Treatment: An Examination of Tubing Technologies

    Outward Appearance: Reviewing Surface Treatment Options

    Face to (Virtual) Face: Telemedicine Now and Post-Pandemic

    Voices for Medtech: AdvaMed and MDMA Leaders Share Thoughts

    Digitize Your QMS via an Enterprise Cloud Platform
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    CMS Establishes New Payment for Pelvalon’s Eclipse System

    Varian, Google Cloud Partner to Bring Convenience to Cancer Therapy

    Resonetics Leases New Manufacturing Space in Costa Rica

    Seisa Medical Acquires ProtoQuick and Peridot

    Masimo Device is Useful in Assessing Respiratory Status of Pediatric Tracheostomy Patients
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Transporting Treatment: An Examination of Tubing Technologies

    Outward Appearance: Reviewing Surface Treatment Options

    Face to (Virtual) Face: Telemedicine Now and Post-Pandemic

    Voices for Medtech: AdvaMed and MDMA Leaders Share Thoughts

    Digitize Your QMS via an Enterprise Cloud Platform
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Home Is Where the Heart (Valve) Is

    CGM: Digital Health Meets a Very Large Opportunity

    Biomechanical Engineer, Heal Thyself

    Optimizing MIM in Medical Device Manufacturing

    PPE and Diagnostics: Sourcing Domestically and Speeding Time to Market
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Medbio LLC

    K-Tube Technologies

    Concise Engineering

    FUTEK Advanced Sensor Technology Inc.

    PTI Engineered Plastics Inc.
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Three Future Trends and Opportunities in Quality Assurance

    Adopting a Data-Driven Quality Model

    Digital Transformation for Quality and Manufacturing

    Digging into the Cardiac Arrhythmia Monitoring Device Market

    EMS Providers Supplying More Than Electronics to Customers
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Medicoil

    Creganna Medical, part of TE Connectivity

    PTI Engineered Plastics Inc.

    FUTEK Advanced Sensor Technology Inc.

    Medbio LLC
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    Election Impact and the Beginning of the 116th Congress

    ...

    Election Impact and the Beginning of the 116th Congress
    Related CONTENT
    • Discerning Medtech’s Path in 2019
    • Continuing on the 510(k) Pathway or Finding a Different Route?
    • Should Medical Device Companies Be Toasting A New Year’s Regulation?
    • Sounding Board: 2018 Reflections and Looking Ahead
    • Reworked Tax Relief Package Could Delay Medical Device Tax Five More Years
    Jeffrey J. Kimbell and David C. Rudloff, Jeffrey J. Kimbell & Associates Inc.01.31.19
    Much has transpired in Washington since the last column that is sure to affect the political landscape as well as manufacturers of medical products. On Nov. 6, over 113 million people voted in elections for all 435 members of the U.S. House of Representatives, roughly one third of the U.S. Senate, 36 governorships, and various state and local races. The result is a divided Congress, as Democrats obtained a majority in the House and Republicans expanded their Senate majority. On the House side, a Democratic wave emerged, with Democratic candidates flipping 40 Republican-held seats. Republicans suffered the most losses in suburban areas, where President Trump’s approval rating is particularly low. Democrats are now left with a substantial 235-199 House majority with one race, North Carolina’s 9th district, undecided.

    In the Senate races, President Trump’s approval appeared to be a boon to Republican challengers hoping to oust Democratic Senators in red states. Republicans were able to flip four Democratic Senate seats in Florida, Indiana, Missouri, and North Dakota. However, the President appeared to hurt Republican candidates in purple states where he is not particularly popular, as Republicans lost two previously held Senate seats in Nevada and Arizona. Regardless, Republicans expanded their Senate majority to a 53-47 seat advantage, which should give Senate Majority Leader Mitch McConnell (R-KY) slightly more breathing room on close votes.

    Democrats also performed well at the state level, flipping control of seven governorships. On election day, Democrats also picked up control of seven state legislative chambers. Since the election of President Trump in 2016, state-level Democrats have broken five Republican supermajorities and flipped 380 legislative seats. This is not unprecedented, since the party out of the White House usually picks up seats in Congress and state governments, as was the case for Republicans during the Obama years.

    The 2018 midterm elections were particularly notable due to the unprecedented level of voter participation. Over 49 percent of eligible voters turned out on election day, making 2018 the highest level of turnout for a midterm election in 104 years. Another unparalleled aspect was spending, estimated at over $5 billion, which would make 2018 the most expensive midterm election cycle to date. Both parties raised massive amounts of money, but Democrats outraised Republicans by over $700 million, which certainly helped their candidates down ballot. Noteworthy to members of the life science community, healthcare was the number one issue for voters cited in exit polls. To their advantage, Democrats campaigned heavily, and won, on healthcare, with Democratic outside groups spending nearly half of their dollars on healthcare ads in both House and Senate races. This is particularly important given the significant number of new Democratic members who will seek to make healthcare reform a priority in the new Democrat-controlled House. Also affecting the dynamics of the new Congress is the fact the House lost some of its biggest life science champions in the midterm elections, as Rep. Erik Paulsen (R-MN), who led House efforts to repeal the device tax; Rep. Mimi Walters (R-CA), a champion of healthcare innovation; and Rep. Peter Roskam (R-IL), the former Chairman of the House Ways and Means Health Subcommittee, were all defeated in November.

    116th Congress Begins
    The new year will bring much change to Washington as Democrats will have control of the House for the first time in eight years. On Jan. 3, Democrats elected Nancy Pelosi (D-CA) to be Speaker of the House; she returns to the position after serving as Speaker from 2007-2011. Democratic leadership has a number of priorities geared up for the new Congress such as campaign finance reform, legal status for Dreamers, and gun control. For healthcare, which remains at the top of the list of Democratic priorities, the House plans to go after healthcare and prescription drug costs, protect the Affordable Care Act (ACA), further address the opioid crisis, support Medicaid expansion, and consider Medicare for all. With control of the committees, House Democrats also plan to investigate drug companies and CEOs responsible for the opioid crisis as well as raising the price of pharmaceuticals.

    With the Senate still in Republican hands, many of House Democrats’ ambitious proposals may be sidelined, but there are a few potential areas of bipartisanship. A Democratic House appears to be more fertile ground for legislation to stabilize the ACA’s insurance markets such as the bipartisan Alexander-Murray bill, which failed to reach the House or Senate floor last year. Additionally, there could be some bipartisan commitment to examine drug pricing legislation. Recently, the Trump Administration proposed policies that seek to lower the cost of drugs in Medicare Part B and Part D. With the President and the Administration on board, a Republican Senate could be swayed to support such measures.

    As of late January, any legislative priorities for the 116th Congress are currently tied up in the partial government shutdown, which began Dec. 22, 2018. The shutdown began as funding for some federal agencies expired due to an impasse over border wall money between Congressional Democrats and the White House. President Trump threatened to veto legislation that does not include border wall funding, and Senate Majority Leader McConnell said the Senate would only take up legislation to end the shutdown that has the support of the President. Senate Minority Leader Chuck Schumer (D-NY) and Speaker Pelosi have stated they will not support any funding for a border wall. Of note to the medical device industry, the shutdown impacts the U.S. Food and Drug Administration (FDA), among other agencies. The FDA will continue to accept device applications that do not require a user fee and will continue working on applications filed before the shutdown, as well as respond to public health emergencies. The FDA will not continue some routine regulatory and compliance activities related to medical products, including routine facility inspections or new product applications requiring a user fee, which may affect the device sector and the development and approval of novel innovative medical technologies.

    Impact on the Device Industry Medical Device Tax
    One of the most critical federal issues facing manufacturers of medical devices in the 116th Congress is the re-establishment of the 2.3 percent excise tax on medical devices, which will go into effect Jan. 1, 2020, unless it is eliminated or suspended. A last-ditch effort to delay the tax for five additional years failed at the end of the last Congress. On Dec. 20, 2018, the House passed H.R. 88, “The Retirement, Savings, and Other Tax Relief Act,” which included a provision to suspend the medical device tax until Jan. 1, 2025. However, the Senate failed to take up the legislation before the end of the 115th Congress on Jan. 3, so any legislative fix to the tax must be re-introduced in the new Congress. The new Democrat-controlled House poses a more challenging landscape for device tax relief as many Democrats view repealing the tax as a handout to industry and as a tool to defund Obamacare. Only 57 House Democrats supported H.R. 184, “The Protect Medical Innovation Act,” which would have fully repealed the tax and passed the Republican House in July.

    Affordable Care Act
    It appears that legislative efforts to eliminate the Affordable Care Act (ACA) are over, given the House is now in Democratic control. Furthermore, in the House midterm elections, many Democratic challengers defeated incumbent Republicans on charges that these Republicans would eliminate protections for preexisting conditions by getting rid of the ACA. Repealing the ACA has become politically unpopular, as nearly 75 percent of the public say it’s important that ACA’s protections for people with preexisting conditions remain law, according to a Kaiser Health Tracking Poll. The future of the ACA is further complicated by a Dec. 14, 2018, ruling by U.S. Federal District Court Judge Reed O’Connor of Texas. O’Connor ruled that the individual mandate in the ACA is unconstitutional due to its elimination following passage of the Tax Cuts and Jobs Act of 2017, as well as inseverable from the entire ACA. Without the mandate serving as a tax to enforce the ACA, Judge O’Connor determined the entire law is invalid. O’Connor’s ruling has received significant pushback and is sure to be appealed to the U.S. Supreme Court. The ruling could have a significant near-term impact as the medical device excise tax was created as part of the ACA, and may be invalidated depending upon the fate of O’Connor’s ruling. Additionally, the case will jumpstart efforts in the 116th Congress to shore up support for the ACA and coverage of preexisting conditions. Already, Speaker Pelosi has called for a vote on a standalone resolution affirming the House’s authorization to intervene in state lawsuits challenging the constitutionality of the ACA.

    Oversight and Investigations
    Another priority for a Democratic House is more oversight and regulation of the healthcare industry in general. Chairman of the House Oversight and Government Reform Committee Elijah Cummings (D-MD) has stated he intends to bring pharmaceutical company CEOs in to testify before Congress to explain the high costs of drugs. Following suit, House Energy and Commerce Committee Chairman Frank Pallone (D-NJ) and House Ways and Means Committee Chairman Richard Neal (D-MA) have both declared the high price of healthcare to be a top priority for their respective committees. House committee chairs have the authority to unilaterally issue subpoenas to launch investigations, including the authority to demand company documents, hold private meetings with corporations, conduct hearings, and compel testimony. While pricing criticism of late is mostly confined to the drug industry, devices are not immune from being looped into the conversation. Expect the 116th Congress to put significant scrutiny on manufacturers of healthcare products in general as House Democrats could use investigations to draw public attention and influence companies’ business strategies and operations. 


    Jeffrey J. Kimbell, president and founder of Jeffrey J. Kimbell & Associates Inc., represents 35 clients in the life sciences community seeking legislative and policy remedies in Washington. Founded in 1998, the firm provides strategic solutions to hand-selected clients seeking creation, modification, or proper implementation of public law.

    David C. Rudloff is a manager of government relations at Jeffrey J. Kimbell & Associates, Inc. He previously worked as a litigation paralegal at Covington & Burling in Washington, D.C. David graduated from Davidson College in 2016 with a B.A. in political science. 
    Related Searches
    • congress
    • tax
    • innovation
    • medical device
    Suggested For You
    Discerning Medtech’s Path in 2019 Discerning Medtech’s Path in 2019
    Continuing on the 510(k) Pathway or Finding a Different Route? Continuing on the 510(k) Pathway or Finding a Different Route?
    Should Medical Device Companies Be Toasting A New Year’s Regulation? Should Medical Device Companies Be Toasting A New Year’s Regulation?
    Sounding Board: 2018 Reflections and Looking Ahead Sounding Board: 2018 Reflections and Looking Ahead
    Reworked Tax Relief Package Could Delay Medical Device Tax Five More Years Reworked Tax Relief Package Could Delay Medical Device Tax Five More Years
    My Holiday Wish List (for Industry) My Holiday Wish List (for Industry)
    FDA Plans to Modernize 510(k) Program FDA Plans to Modernize 510(k) Program
    With Trump’s Space Force Idea Gaining Steam, Could a U.S. Health Force Be Far Behind? With Trump’s Space Force Idea Gaining Steam, Could a U.S. Health Force Be Far Behind?
    Spotlight on Recent Legislation and the 2018 Midterm Elections Spotlight on Recent Legislation and the 2018 Midterm Elections
    Damning Documentary or Tugging at Heartstrings? A Look at ‘The Bleeding Edge’ Damning Documentary or Tugging at Heartstrings? A Look at ‘The Bleeding Edge’
    Improved Quality of Life, Reduced Symptoms Shown in Patients Treated With Medtronic Cryoballoon Improved Quality of Life, Reduced Symptoms Shown in Patients Treated With Medtronic Cryoballoon

    Related Columns

    • Cardiovascular | Surgical
      Home Is Where the Heart (Valve) Is

      Home Is Where the Heart (Valve) Is

      Artificial heart valve makers reached a number of milestones despite the pandemic’s global squeeze.
      Sam Brusco, Associate Editor 04.01.21

    • Chronic Disease | Digital Health | Patient Monitoring
      CGM: Digital Health Meets a Very Large Opportunity

      CGM: Digital Health Meets a Very Large Opportunity

      Continuous glucose monitors (CGMs) are one of the most formidable diabetes management tools to be developed in decades.
      Maria Shepherd, President and Founder, Medi-Vantage 04.01.21

    • Surgical
      Biomechanical Engineer, Heal Thyself

      Biomechanical Engineer, Heal Thyself

      Choosing a treatment option for spinal disorders can be tricky with extensive knowledge of the industry.
      Dawn A. Lissy, Founder & President, Empirical 04.01.21


    • Molding | Surgical
      Optimizing MIM in Medical Device Manufacturing

      Optimizing MIM in Medical Device Manufacturing

      Metal injection molding (MIM) is a good choice for producing medium- to high-volume medtech parts.
      Steve Santoro, Executive Vice President, MICRO 04.01.21

    • Diagnostics
      PPE and Diagnostics: Sourcing Domestically and Speeding Time to Market

      PPE and Diagnostics: Sourcing Domestically and Speeding Time to Market

      With smart onshoring strategies, the medical device industry can collaborate to fix supply chain issues.
      Claudio Hanna and Ralph Tricomi , Web Industries 04.01.21

    • Testing
      The Evolution of Chemical Characterization for Medical Devices

      The Evolution of Chemical Characterization for Medical Devices

      Evaluation of biological safety of devices is experiencing some of the most significant changes in history.
      Sandi Schaible, Senior Director, Analytical Chemistry and Regulatory Toxicology, WuXi AppTec Medical Device Testing 04.01.21


    • Digital Health
      How Digital Health Fits into the Medtech Mold

      How Digital Health Fits into the Medtech Mold

      Healthcare will need to adopt digital technologies that streamline and enhance connectivity.
      Florence Joffroy-Black and Dave Sheppard, MedWorld Advisors 04.01.21

    • Global Supply Chain Wisdom from Coronavirus-Colored Lenses

      Global Supply Chain Wisdom from Coronavirus-Colored Lenses

      There are precious pearls of wisdom from this past year that will come in handy during the next “crisis.”
      Chris Oleksy, Founder and CEO, Oleksy Enterprises and Co-Founder Next Life Medical; CEO, Emergent Respiratory 04.01.21

    • Four Considerations When Selling to a Private Equity Fund

      Four Considerations When Selling to a Private Equity Fund

      A private equity partner can help medtech firms expand into new markets and serve existing clients better.
      Bill Hadler and Anisa Mohanty, McDermott Will & Emery 04.01.21


    • Software & IT
      Cybersecurity Compromises, Courtesy of COVID-19

      Cybersecurity Compromises, Courtesy of COVID-19

      As the healthcare industry focused its energies last year on battling SARS-CoV-2, cybercriminals used the distraction to their advantage.
      Michael Barbella, Managing Editor 03.04.21

    • A Look at the Actual Device Costs for Hospitals

      A Look at the Actual Device Costs for Hospitals

      According to a 2018 clinical journal article, U.S. hospitals spent approximately $200 billion on medical devices.
      Maria Shepherd, President and Founder, Medi-Vantage 03.04.21

    • Show Time: Here’s What a Year of No Tradeshows Meant for Small Businesses

      Show Time: Here’s What a Year of No Tradeshows Meant for Small Businesses

      For small businesses, trade shows are a critical part of developing new business as well as maintaining contacts.
      Dawn A. Lissy, Founder & President, Empirical 03.04.21


    • FDA Making Progress With Technology and Data Action Plans

      FDA Making Progress With Technology and Data Action Plans

      There is an urgent need to get advanced technologies into the healthcare ecosystem, but all products must first get regulatory approval.
      Alan Rencher, Vice President, Engineering, MasterControl 03.04.21

    • What’s Hot Now in Medtech M&A

      What’s Hot Now in Medtech M&A

      Every M&A cycle in the life sciences/medtech sector fosters exciting deals that interestingly impact the industry in both the short and long term.
      Florence Joffroy-Black and Dave Sheppard, MedWorld Advisors 03.04.21

    • Software & IT
      Three Ways to Fast-Track the Total Product Lifecycle

      Three Ways to Fast-Track the Total Product Lifecycle

      Here are three ways leaders including Alcon, Baxter Healthcare, Boston Scientific, Epredia, and Illumina are driving innovation in medtech.
      Seth Goldenberg, Ph.D., Vice President, MedTech, Veeva Systems 03.04.21


    Trending
    • 5 Ways Plastics Revolutionized The Healthcare Industry
    • Portable, Home-Use Device Quickly Measures Inflammation Levels
    • Face Mask Filters 98 Percent Of COVID-19 Particles
    • Cheetah Medical Introduces Noninvasive Monitoring System
    • Top 10 Trends In The Medical Device And Equipment Industry
    Breaking News
    • CMS Establishes New Payment for Pelvalon’s Eclipse System
    • Varian, Google Cloud Partner to Bring Convenience to Cancer Therapy
    • Resonetics Leases New Manufacturing Space in Costa Rica
    • Seisa Medical Acquires ProtoQuick and Peridot
    • Masimo Device is Useful in Assessing Respiratory Status of Pediatric Tracheostomy Patients
    View Breaking News >
    CURRENT ISSUE

    April 2021

    • Transporting Treatment: An Examination of Tubing Technologies
    • Face to (Virtual) Face: Telemedicine Now and Post-Pandemic
    • Outward Appearance: Reviewing Surface Treatment Options
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Kyowa Hakko Launches Heat-Treated Probiotic Strain for Eye Health
    CGA-7 Green Coffee Extract by Vidya Herbs Achieves Self-Affirmed GRAS Status
    Nutritional Complex Evidenced to Reduce Preterm Birth
    Coatings World

    Latest Breaking News From Coatings World

    Chromaflo Technologies to Sponsor and Exhibit at the North American Pultrusion Conference 2021
    Barentz Expands Canadian CASE Team
    Shepherd Color Company Opens Sales Office in China
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    CMS Establishes New Payment for Pelvalon’s Eclipse System
    Varian, Google Cloud Partner to Bring Convenience to Cancer Therapy
    Resonetics Leases New Manufacturing Space in Costa Rica
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ
    Ascendia Pharmaceuticals Poised for Expansion
    Bora Pharmaceuticals Adds Roller Compaction Capabilities
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Revlon Unveils New Fragrances Featuring Megan Thee Stallion & Sofia Carson
    Henkel Management Board Welcomes Wolfgang König
    Mielle Organics Gets a Major Investment
    Happi

    Latest Breaking News From Happi

    Nature’s Beauty Debuts Vegan Natural Body Care at Walgreens
    Estée Lauder Expands Beautiful Fragrance Collection
    The Honest Company Files for IPO
    Ink World

    Latest Breaking News From Ink World

    SE-DA Invests in Kornit Presto S
    Kumon North America Adds Speedmaster XL 106 from Heidelberg
    Iron Oxide Pigments Market to Register 4.7% CAGR from 2021 to 2028: GVR
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Dantex elevates Joseph Sanchez to digital business development manager
    Mactac's Kevin Clunie joins TLMI panel
    MacDermid announces two new global sales roles
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Precision Textiles Offers Biodegradable Medical Fabric
    Northshore Launches Megamax Briefs in New Colors
    Essity Acquires Distribution Rights to Sorbact in Australia and New Zealand
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    New Biosealant Could Stabilize Cartilage, Boost Healing After Injury
    Google Executive Joins SeaSpine's Board of Directors
    HSS and LimaCorporate Open Provider-Based 3D Design and Printing Facility
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Tive Multi-sensor Tracker Solo 5G Relies on Sensirion SHT33
    VTT in 2020: Successful Year Despite Globally Challenging Times
    Lux Research: 3D Printing Market to Reach $51 Billion in 2030

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login